Unknown

Who we are

  • April 5, 2022
    Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases
  • April 5, 2022
    Pembrolizumab After Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Who Are Undergoing Liver Surgery
  • April 5, 2022
    Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM.
  • April 5, 2022
    A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors
  • April 5, 2022
    Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
  • April 5, 2022
    Adoptive Cell Therapy Across Cancer Diagnoses
  • April 5, 2022
    Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor
  • April 5, 2022
    Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
  • April 5, 2022
    Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer
  • April 5, 2022
    Geptanolimab(GB226) Combined With Fruquintinib in the Treatment of Metastatic Colorectal Cancer